Tremendous surge in the industrialization and infrastructure development worldwide have led to a significant rise in environmental pollutants in the last 2–3 decades. Pollutants in the natural environment consist of highly diversified and complex mixtures. A single biomarker cannot be used to assess a complete identification of environmental pollutants. In this context, it is highly recommended by environmental scientists to evaluate a set of complementary biomarkers for the complete assessment of toxic burden of complex environmental pollutants in the exposed organisms.

Despite extensive research for over two decades, the medical science is yet to assign the exact aetiology and mode of progression of Alzheimer's disease (AD). The modern era of AD drug development began with the proposal of the cholinergic hypothesis of memory impairment. Since then, despite the proposal and phase trials of many therapeutic options, only few drugs have shown some efficacy and safety. The reasons behind this have been many including the ineffectiveness of tested drugs and inadequacy of clinical development methods.